Dark Lumen MR colonography vs. Colonoscopy for the detection of colorectal lesions

Dark Lumen MR colonography vs. Colonoscopy for the detection of colorectal lesions - MR colonography Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32956

Enrollment

110

Registered

2009-11-20

Start date

2009-09-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal carcinoma large bowel cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Symptomatic CRC patients ( rectal blood loss, altered bowel habits) -Patients scheduled to undergo colonoscopy -Patients who are willing to give informed consent

Exclusion criteria

Exclusion criteria: -Age of less than 18 years -patients who were unable to give informed consent -any suspicion of bowel perforation or pathologic obstruction in subjects* medical history -contraindications for oral or intravenous administration of contrast agents as used for this examination -oral or intravenous administration of barium contrast medium within 48 hours prior to MR colonography (barium enema) -presence of a colostomy after colorectal surgery -contraindications to undergo MRI (including claustrophobia, metallic implants and pregnancy)

Design outcomes

Primary

Measure	Time frame
The main study endpoint is the diagnostic accuracy of MR colonography in detecting patients with colorectal carcinoma (CRC) , clinical relevant polyps (* 10mm) and intermediate polyps (6-9mm).	—

Secondary

Measure	Time frame
Secondary endpoints are evaluation of the per-polyp detection and patient acceptance.	—

Countries

Netherlands

Outcome results